Trials that use: P-values
New to this method? Read the tutorial →
20,601 results
- Genetic Effects on Dopamine Response to an Opiate: Complete Statistical AnalysisIndependent statistical analysis of Genetic Effects on Dopamine Response to an Opiate: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01878006).
- Genetic Predictors of Benefit to Pembrolizumab: Complete Statistical AnalysisIndependent statistical analysis of Genetic Predictors of Benefit to Pembrolizumab: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02710396).
- Genetic Research in Schizophrenia Using DNA Markers and Clinical Phenotypes: Complete Statistical AnalysisIndependent statistical analysis of Genetic Research in Schizophrenia Using DNA Markers and Clinical Phenotypes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00108303).
- Genetic Screening for Filaggrin Mutation in Atopic Dermatitis and Ichthyosis Vulgaris in the African American Population: Complete Statistical AnalysisIndependent statistical analysis of Genetic Screening for Filaggrin Mutation in Atopic Dermatitis and Ichthyosis Vulgaris in the African American Population: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Genetic Variates of Response to Cisplatin, Vinblastine, and Temozolomide (CVT) in Patients With Metastatic Melanoma: Complete Statistical AnalysisIndependent statistical analysis of Genetic Variates of Response to Cisplatin, Vinblastine, and Temozolomide (CVT) in Patients With Metastatic Melanoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Genetically Determined Response to Atenolol in Patients With Persistent Atrial Fibrillation: Complete Statistical AnalysisIndependent statistical analysis of Genetically Determined Response to Atenolol in Patients With Persistent Atrial Fibrillation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Genetically Modified Neural Stem Cells, Flucytosine, and Leucovorin for Treating Patients With Recurrent High-Grade Gliomas: Complete Statistical AnalysisIndependent statistical analysis of Genetically Modified Neural Stem Cells, Flucytosine, and Leucovorin for Treating Patients With Recurrent High-Grade Gliomas: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Genetically Modified T Cells in Treating Patients With Stage III-IV Non-small Cell Lung Cancer or Mesothelioma: Complete Statistical AnalysisIndependent statistical analysis of Genetically Modified T Cells in Treating Patients With Stage III-IV Non-small Cell Lung Cancer or Mesothelioma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Geniculate Artery Embolization for Knee Pain Secondary to Osteoarthritis (OA): Complete Statistical AnalysisIndependent statistical analysis of Geniculate Artery Embolization for Knee Pain Secondary to Osteoarthritis (OA): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03362957).
- GeniProIndependent statistical analysis of Genistein Supplementation to Mitigate Cardiometabolic Dysfunction in Patients Undergoing Androgen Deprivation Therapy for Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Genistein, Gemcitabine, and Erlotinib in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer: Complete Statistical AnalysisIndependent statistical analysis of Genistein, Gemcitabine, and Erlotinib in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Genomic Markers Before and After Treatment of Actinic Keratosis With Imiquimod 3.75% Cream: Complete Statistical AnalysisIndependent statistical analysis of Genomic Markers Before and After Treatment of Actinic Keratosis With Imiquimod 3.75% Cream: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Genotype-supported Versus Conventional Proton Pump Inhibitor Dosing: Complete Statistical AnalysisIndependent statistical analysis of Genotype-supported Versus Conventional Proton Pump Inhibitor Dosing: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02930824).
- Gentamicin Bladder Instillations to Prevent Urinary Tract Infections in Patients With Spinal Cord Injury: Complete Statistical AnalysisIndependent statistical analysis of Gentamicin Bladder Instillations to Prevent Urinary Tract Infections in Patients With Spinal Cord Injury: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- GeoScan and Remote Geo Smoking Study: Neural and Behavioral Correlates of Smokers’ Exposure to Retail Environments: Complete Statistical AnalysisIndependent statistical analysis of GeoScan and Remote Geo Smoking Study: Neural and Behavioral Correlates of Smokers' Exposure to Retail Environments: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- GER Poses a Potential Risk for Late Complications of BPD: Complete Statistical AnalysisIndependent statistical analysis of GER Poses a Potential Risk for Late Complications of BPD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03014453).
- Geriatric Ketamine for Pain Management Study: Complete Statistical AnalysisIndependent statistical analysis of Geriatric Ketamine for Pain Management Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02673372).
- Gestational Weight Gain and Postpartum Weight Loss in Active Duty Women (Moms Fit 2 Fight): Complete Statistical AnalysisIndependent statistical analysis of Gestational Weight Gain and Postpartum Weight Loss in Active Duty Women (Moms Fit 2 Fight): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Get Social: Randomized Trial of a Social Network Delivered Lifestyle Intervention: Complete Statistical AnalysisIndependent statistical analysis of Get Social: Randomized Trial of a Social Network Delivered Lifestyle Intervention: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- GET-PrEPDIndependent statistical analysis of Goal Elicitation, Treatment Prioritization, & Electronically-Practiced Discussion for Psychiatry: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04601194).
- GETGOAL-LIndependent statistical analysis of GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Basal Insulin: primary endpoint results, effect estimate with confidence…
- GETGOAL-L-ASIAIndependent statistical analysis of GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Basal Insulin +/- Sulfonylurea (GETGOAL-L-ASIA): primary endpoint results, effect…
- GETGOAL-MONOIndependent statistical analysis of GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation in Monotherapy: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- GetGoal-OIndependent statistical analysis of Efficacy and Safety of Lixisenatide Versus Placebo on Top of Basal Insulin and/or Oral Antidiabetic Treatment in Older Type 2 Diabetic Patients: primary endpoint results, effect estimate with…
- GETUGV04Independent statistical analysis of A Phase II Trial Evaluating an Organ-conserving Strategy by Radiochemotherapy for Muscle-infiltrative Bladder Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- GIANTIndependent statistical analysis of Phase 4 Study to Assess the Effect of Bisoprolol on Glycemic Level in Type II Diabetic Subjects With Suboptimal Blood Pressure Control: primary endpoint results, effect estimate with…
- GIANTIndependent statistical analysis of Adjuvant Treatment With a Glycine Uptake Inhibitor in Participants With Negative Symptoms of Schizophrenia (P05695) (MK-8435-001): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- GIFTIndependent statistical analysis of Unacylated Ghrelin to Improve FuncTioning in PAD: The GIFT Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03358355).
- GIFTIIIndependent statistical analysis of Unacylated Ghrelin to Improve Functioning in PAD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04377126).
- GINGERIndependent statistical analysis of Ginger's Therapeutic Potential in Asthma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03705832).
- Ginger Capsules for the Acute Treatment of Migraine Attacks: Complete Statistical AnalysisIndependent statistical analysis of Ginger Capsules for the Acute Treatment of Migraine Attacks: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02568644).
- Gingival Crevicular Fluid Characterization During Orthodontic Treatment: Complete Statistical AnalysisIndependent statistical analysis of Gingival Crevicular Fluid Characterization During Orthodontic Treatment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04226469).
- Girls on the Move Intervention to Increase Physical Activity Among Middle School Girls: Complete Statistical AnalysisIndependent statistical analysis of Girls on the Move Intervention to Increase Physical Activity Among Middle School Girls: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- GIVERIndependent statistical analysis of Use of Telehealth In-home Messaging to Improve GI (Gastrointestinal) Endoscopy Completion Rates: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- GKT137831Independent statistical analysis of GKT137831 in IPF Patients With Idiopathic Pulmonary Fibrosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03865927).
- Glargine Dosing in Hospitalized Patients With Type 2 Diabetes and Renal Insufficiency: Complete Statistical AnalysisIndependent statistical analysis of Glargine Dosing in Hospitalized Patients With Type 2 Diabetes and Renal Insufficiency: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- GLASSIA Safety, Immunogenicity, and Bronchoalveolar Lavage Study: Complete Statistical AnalysisIndependent statistical analysis of GLASSIA Safety, Immunogenicity, and Bronchoalveolar Lavage Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02525861).
- GLEAMIndependent statistical analysis of A Trial to Evaluate the Efficacy, Durability, and Safety of KSI-301 Compared to Aflibercept in Participants With Diabetic Macular Edema (DME): primary endpoint results, effect estimate with confidence…
- Glembatumumab Vedotin in Treating Patients With Metastatic or Locally Recurrent Uveal Melanoma: Complete Statistical AnalysisIndependent statistical analysis of Glembatumumab Vedotin in Treating Patients With Metastatic or Locally Recurrent Uveal Melanoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Gliadel Wafer and Fluorescence-Guided Surgery With 5-ALA Followed by Radiation Therapy And Temozolomide in Treating Patients With Primary Glioblastoma: Complete Statistical AnalysisIndependent statistical analysis of Gliadel Wafer and Fluorescence-Guided Surgery With 5-ALA Followed by Radiation Therapy And Temozolomide in Treating Patients With Primary Glioblastoma: primary endpoint results, effect estimate with confidence interval, sample-size…
- GLIDERIndependent statistical analysis of A Study Evaluating the Effects of GLPG3970 Given as an Oral Treatment for 12 Weeks in Adults With Active Primary Sjögren's Syndrome (pSS): primary endpoint results, effect estimate…
- GlideScope Versus Direct Laryngoscope for Emergency Intubation: Complete Statistical AnalysisIndependent statistical analysis of GlideScope Versus Direct Laryngoscope for Emergency Intubation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01235065).
- GlideScope Video Laryngoscope Versus Fiberoptic Intubation: Complete Statistical AnalysisIndependent statistical analysis of GlideScope Video Laryngoscope Versus Fiberoptic Intubation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01091948).
- GlideScope®Video Laryngoscope for Difficult Intubation: Implication of the Size of Blade: Complete Statistical AnalysisIndependent statistical analysis of GlideScope®Video Laryngoscope for Difficult Intubation: Implication of the Size of Blade: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- GLIDINGIndependent statistical analysis of Comparison of Glargine to Degludec Insulin Transition With or Without a Bridging Glargine Dose: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Glimepiride 4 mg Tablets Under Non-Fasting Conditions: Complete Statistical AnalysisIndependent statistical analysis of Glimepiride 4 mg Tablets Under Non-Fasting Conditions: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00835172).
- GLIMPIndependent statistical analysis of Effects of GLP1-RA on Ectopic Fat Deposition in Chronic Kidney Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- GLITTER 2Independent statistical analysis of Gan & Lee Insulin Glargine Target Type (2) Evaluating Research: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03371108).
- GLITTER1Independent statistical analysis of Gan & Lee Insulin Glargine Target Type (1) Evaluating Research: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03371082).
- Global Prospective Case Series Using a Single-Use Duodenoscope: Complete Statistical AnalysisIndependent statistical analysis of Global Prospective Case Series Using a Single-Use Duodenoscope: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04103749).